e-Drug3D 614 |
ENOXACIN DISCONTINUED
|
cas 74011-58-8 |
CLASS ANTIINFECTIVES |
ROUTE (list) ORAL |
ATC code |
PK parameters F 90 PERCENT |
Target TARGET DNA GYRASE |
DrugCentral Topoisomerase IV UNIPROT P48374 parC DNA gyrase UNIPROT P22118 gyrB |
Download SDF file | 1-ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,8-naphthyridine-3-carboxylic acid Formula: Calculated chemical properties: MW 319.32 NB_atoms 23 XLogP -0.67 PSA 80.322 NB_HD 1 NB_HA 7 fsp3 0.40 Lipinski(0=no;1=yes) 1 |
FDA NDA 019616 (pdf not found) INN (ENOXACIN) PENETREX (SANOFI AVENTIS US) APPROVAL= AP YEAR= 1991 NEWMOLECULARENTITY DISCONTINUED |
Other links: |